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Abstract:
Klebsiella pneumoniae is an opportunistic pathogen responsible for lobar pneumoniae,
liver abscess, and septicemia. Clinical isolates are found to be extended spectrum beta lactamase
positive with differential expression of the two classical porins, OmpK35 and OmpK36. Porin loss
is associated with increased minimum inhibitory concentrations of beta lactam, cephalosporin, and
carbapenem antibiotics that target the peptidoglycan. However, little is known about how porin
loss affects other aspects of the cell envelope. The focus of this study was to characterize clinical
isolates exhibiting differential porin expression and determine if the cumulative changes altered
the resistance to phagocytosis by macrophages. The results support the hypothesis that porin loss
significantly impacts the overall cell envelope composition, which in turn alters interactions with
macrophages.

Chapter 1
Introduction
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Outer membrane composition and permeability can lead to increased antibiotic
resistance
Gram-negative bacteria are distinguished as having both an inner and an outer plasma
membrane that is separated by a thin layer of peptidoglycan within the periplasmic space (Figure
1). This creates a stable cell envelope with two selectively permeable membranes that separate the
inside of the cell from the environment. Maintenance of the cell envelope is crucial to the survival
of the organism. The outer membrane is chemically distinct from the inner membrane. The
phospholipids of the outer leaflet are modified and are known as the immunogenic
lipopolysaccharide (LPS). It is also known as endotoxin due to its toxic nature in mammalian hosts
and interactions with LPS and host immune cells have been well documented 1–3.

Figure 1. Gram-negative bacteria cell envelope consists of an inner and outer plasma membrane separated by a thin
layer of peptidoglycan. The outer leaflet of the outer membrane consists of lipopolysaccharide (LPS) and is surrounded
by capsular polysaccharide. Embedded within the outer membrane are proteins including porins that allow the passive
diffusion of small molecules into the periplasmic space4.
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The other major components of the outer membrane encountered by host immune cells are
outer membrane proteins which are potentially important virulence factors. The functions of these
proteins include adherence to surfaces, cell to cell communication, and transport of molecules
across the membrane. Non-specific transport of molecules from the exterior environment to the
periplasmic space is handled by outer membrane proteins that create pores in the membrane and
are thus called outer membrane porins5–9. Porins have recently been shown to also be important to
interactions between the bacteria and the host immune system, particularly the evasion of
phagocytosis2,10.
Major, common porins OmpC and OmpF have been well characterized in Escherichia
coli9,11. These porins have several homologues in various Gram-negative species, including
Klebsiella pneumoniae which are denoted as OmpK36 and OmpK35 respectively7,8. Porins are
beta barrel proteins that form a homotrimer in the outer membrane (Figure 2). This creates a
central pore that allows for the passive diffusion of small hydrophilic molecules into the
periplasmic space.
OmpK35 and OmpK36 are both non-specific porins of slightly different molecular weight
(35kDa and 36kDa respectively). The two major porins are highly similar in function, but have
been shown to differ in permeability. In E. coli, OmpF (OmpK35 homologue) has a higher rate of
influx for large solutes and is in general more permeable than OmpC (OmpK36 homologue). Using
liposome swelling assays, OmpC was shown to have 15-20% of the permeability to β-lactam
antibiotics compared to OmpF. However, OmpC also retained 50% of the permeability for small
molecules like glucose12. Based on sequence homology, crystal structures, and permeability to βlactam antibiotics; it is assumed that the permeability of OmpK35 and OmpK36 of K. pneumoniae
are similar to their E. coli homologues7,8,13,14. X-ray crystallography structures of both porins have
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Figure 2. OmpK35 and OmpK36 are β-barrel proteins that form a homotrimer within the outer membrane. This creates
a central pore through which small molecules can traverse the outer membrane. A) Proposed structure of OmpK36
monomeric subunit7. B) 3D modeling of OmpK36 homotrimer featuring the central pore8.
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shown a similar pore geometry. Interestingly, it was shown that the increase in charge density of
OmpK36 in comparison to OmpK35, and not pore size, was responsible for the slower influx rates
of solutes8,12.
This difference in the rate of influx of molecules from the exterior of the cell to the
periplasmic space between OmpK35 and OmpK36 could be an evolutionary advantage for the
expression of one porin over the other in contrasting conditions15. While porins play an important
role in nutrient acquisition6,16 the nonspecific nature of these porins also allows the passage of
small antibiotics as well6,7,12. It has been shown in K. pneumoniae that loss of one or both porins
can have a dramatic increase on the organism’s resistance to β-lactam antibiotics. This is because
the target of these antibiotics is the peptidoglycan found in the periplasmic space between the two
membranes5,17–19.
It has been noted during investigations into several clinical outbreaks that decreased outer
membrane porin expression is correlated with an increased minimum inhibitory concentration
(MIC) to multiple classes of antibiotics. More specifically, loss of one or both porins is often
observed in many clinical isolates that can be classified as Extended Spectrum Beta Lactamase
(ESBL) positive or multidrug resistant (MDR)5,15,20–22.

Extended spectrum beta lactamase

enzymes target most β-lactam antibiotics including penicillin and cephalosporin, neutralizing the
antibiotic5.
Surveillance studies on antibiotic resistant clinical isolates have shown that in Klebsiella
pneumoniae, and other enteric species, most ESBL producing isolates have some form of porin
loss. It is more likely to observe the loss of OmpK35 or both porins than it is to observe the loss
of only OmpK36. However, ESBL negative bacteria typically express both porins5,17,23–25. In one
specific study using 52 clinical isolates from a hospital outbreak in Iran, it was shown that 30
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isolates were ESBL negative and maintained expression of both porins. However, of the 22 ESBL
positive isolates, 9 were deficient in OmpK35 only, 4 were deficient in OmpK36 only, and 5 of
the isolates were deficient in both porins26. Another study using 57 carbapenem resistant isolates
(KPC) showed that dual porin loss acted synergistically with carbapenemase to increase
resistance17, and a third showed that of 12 KPC producing isolates, there was no detectable
expression of OmpK3524. Although OmpK36 mutants have been identified in K. pneumoniae, it
still seems apparent that loss of OmpK35 or both porins is more common in antibiotic resistant
clinical isolates than loss of OmpK36 alone6,17,24,27. This is most likely due to the fact that OmpK35
is transcriptionally depressed in environments similar to those found in a human host as well as
when exposed to antibiotics in vitro6,24,26,28.
Infections classified as ESBL positive or MDR caused by Gram-negative bacteria are
common place in hospitals and clinics throughout the world23,29. The rapid adaptation of bacteria
to environmental pressures, including antibiotics and the harsh conditions of the mammalian gut,
have resulted in many alterations to the Gram-negative cell envelope30. This includes loss of one
or both of the major porins, OmpK35 and OmpK365. Expression of the porins is tightly regulated
by multiple environmental response pathways that can be activated by antibiotic stress5,6,30.
Regulation of OmpK35 and OmpK36
Regulation of OmpK35, OmpK36, and other outer membrane proteins occurs through the
coordinated efforts of several regulatory systems. This includes the major two-component stress
response regulators EnvZ/OmpR31,32, and CpxA-CpxR28,32,33. Extensive research on the regulation
of each of these systems has revealed complex pathways that result in transcriptional and post
transcriptional regulation of the porins, resulting in the dominant expression of one porin over the
other, depending on the environmental stressors present.
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EnvZ/OmpR regulation of OmpC and OmpF is based on promoter affinity for the
transcriptional regulator OmpR (Figure 3)34–36. The promoter for ompF has a high affinity for
OmpR and requires lower concentrations to activate transcription. Conversely, the ompC promoter
has a low affinity for OmpR and requires increased concentrations to activate transcription35. The
environmental sensor kinase EnvZ is activated by increased osmolality, higher temperatures, and
low pH37. Activation of EnvZ results in the phosphorylation and activation of OmpR, and an
increased transcription of both ompC and a small inhibitory RNA. This RNA, micF, binds to the
5` end of the ompF transcript and depresses translation35. There is also evidence to support the
hypothesis that at increased levels of activated OmpR, a low affinity binding site close to the ompF
promoter binds OmpR and causes the DNA to fold into a hairpin loop and block transcription of
the porin.35 This allows for the differential expression of OmpF over OmpC in environments low
in nutrient availability, neutral pH, and low temperature like those of the natural environment.
However, in environments similar to those of the host, with high nutrient availability, lower pH,
and increased temperature, OmpC becomes the dominant porin31,35.
The two component CpxA-CpxR envelope stress response system also differentially
regulates the expression of OmpK35 and OmpK36. Similarly, to EnvZ/OmpR, CpxA serves as a
membrane associated sensor kinase and CpxR acts as the regulator of transcription. It has been
shown that CpxA is activated by stress to the outer membrane to include osmolality, pH, surface
adhesion, detergents, and presence of misfolded proteins. Activated CpxA in turn begins a
phosphorylation cascade ultimately resulting in phosphorylation of CpxR (CpxR-P), which then
regulates transcription of target genes. Overexpression of CpxA has been shown to increase the
transcriptional expression of OmpK36 and significantly decrease OmpK35 expression in K.
pneumoniae33.

8

Figure 3. EnvZ/OmpR regulation of ompC/ompF transcription occurs through promoter affinity for the
transcriptional regulator, OmpR. Image is based on previous work by Mattison et al38. A) In low osmolarity
conditions OmpR levels are low. The high affinity ompF promoter binds available OmpR and the low affinity ompC
promoter does not. This promotes transcription of ompF over ompC. B) In high osmolarity conditions, the high
affinity ompF promoter and an upstream response regulator bind OmpR, causing a bend in the DNA and blocks
transcription of ompF. However, the low affinity ompC promoter binds OmpR and activates transcription of ompC.
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CpxA-CpxR has also been shown to be required for K. pneumoniae survival in
environments that mimic the host gastrointestinal tract (GI). This regulatory system is important
in environments containing bile salts, high NaCl concentration, oxidative stressors (hydrogen
peroxide), or disinfectants (chlorohexidine). When CpxA-CpxR was knocked out, survival in the
presence of these materials decreased significantly28. This is fundamentally important for
pathogenicity within a host as colonization within the GI tract is required to establish a K.
pneumoniae infection.39 It was also shown that this stress response system was important for
antibiotic resistance as minimum inhibitory concentrations of several β-lactam antibiotics were
decreased in cpxA-cpxR mutants. Notably, this same study also concluded that the promoter region
of OmpK36 contains a conserved CpxR binding motif that is a transcriptional regulatory site28.
Collectively, these studies indicate the importance of porin regulation in the host environment and
add to the evidence that OmpK36 is an important virulence factor.
This dual regulation of OmpK35 and OmpK36 may have arisen from the evolutionary
advantage of expressing one porin over the other under contrasting conditions as the two porins
allow for different rates of diffusion across the outer membrane8,12. The central pore of OmpK35
is notably more permeable than that of OmpK36 and may be more beneficial for nutrient
acquisition in environments naturally low in salt and carbon sources6,8,12. However, the increased
rate of influx of molecules would be detrimental in environments like the human gut where toxic
components (like bile salts/ proteolytic enzymes/ antibiotics) may be more abundant. Therefore, it
is likely more constructive for the bacteria to down regulate OmpK35 expression and upregulate
OmpK36 as the OmpK36 central pore is less permeable than that of OmpK35. This difference in
pore permeability may decrease the influx of larger molecules that may be harmful to the cell while
still allowing passage of small nutritive molecules like glucose5,7,12,17.
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Porin loss can change the cell surface by impacting expression of other outer membrane
proteins
Porin loss does not only affect the permeability of the outer membrane. Expression of other
outer membrane proteins could also be affected. Specifically, proteins that are involved in nutrient
acquisition, adherence, and outer membrane stability have the greatest potential to be affected.
OmpK26, LamB, OmpA, and Lpp have been determined to be important in the maintenance of the
cell envelope.
OmpK26 is a 26kDa porin similar in structure to OmpK35 and OmpK3640. However, this
porin is specific for oligo galacturonate and will not allow the passage of antibiotics. Under normal
conditions, expression of this porin is inactive and does not appear on an SDS-PAGE gel.
However, OmpK26 was shown to be essential for survival in an OmpK36 deficient strain.
Expression of this porin in the absence of OmpK36, along with the presence of beta lactamase,
confers resistance to carbapenem and β-lactam antibiotics in vitro. This also causes a decrease in
the virulence of the organism in a mouse model40.
LamB is a maltose-specific porin that is permeable to β-lactam antibiotics, but to a lesser
degree than OmpK35 or OmpK3641. It is suspected to be significantly upregulated with dual porin
loss. LamB has been shown to be. In a study using two clinical isolates, one expressing only
OmpK36 and the other expressing neither porin, transcript level of lamB was 2 fold higher in the
dual porin loss isolate41. However, transcriptional expression of lamB has yet to be determined in
comparison to a strain expressing only OmpK35 or both porins.
The outer membrane protein OmpA has shown to be multifunctional and important for
outer membrane stability, pathogenicity, and antimicrobial resistance. The main function of OmpA
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is to link the outer membrane and peptidoglycan via a C-terminal peptidoglycan binding domain.
Linkage of the outer membrane to the peptidoglycan by OmpA has shown to be important to
resistance of tensile stress on the peptidoglycan and support overall integrity of the cell envelope42.
Mounting evidence also suggests OmpA acts as an adhesin and is important for invasion into
epithelial cells and phagocytes43,44. The progression of infection to bacteremia and meningitis
infections in vivo are also OmpA dependent 2,45. In E. coli, OmpA deletion showed an increase in
OmpC on an SDS-PAGE gel46. K. pneumoniae outer membrane vesicles also showed increased
OmpA expression when OmpK35 is lost47. However, the change in transcriptional expression of
OmpA due to porin loss has yet to be determined.
Murein (peptidoglycan) lipoprotein (Lpp) is highly abundant within the outer membrane
and serves to stabilize the cell envelope. The fatty acid moiety is embedded in the outer membrane
and the protein is also covalently linked to the peptidoglycan. Lpp mutants have been shown to
increase production of outer membrane vesicles and leak periplasmic enzymes. This indicates the
importance of Lpp to the outer membrane and the stability of the cell envelope6,27,48. Lpp has also
been indicated in pathogenesis of bacterial infection because Lpp mutants are more susceptible to
serum killing and phagocytosis in vitro48. Although Lpp is essential for membrane stability, no
correlation between porin loss and Lpp expression has been investigated.
Capsular polysaccharide may be altered due to porin loss
Capsular polysaccharide is another important virulence factor for K. pneumoniae. It is
composed of a poly-KDO linker moiety that is associated with the outer membrane, and a Kantigen repeating polysaccharide unit that is serotype specific49. There are approximately 77
known K. pneumoniae capsular serotypes that are highly suggestive of pathogenicity. K1-K6 are
more often associated with respiratory infections and septicemia than others50. Serotypes K1 and
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K2 are the most common culprits for invasive infections51 and K2 is the most prevalent serotype
of clinical isolates52.
All K. pneumoniae serotypes contain the monosaccharide glucuronic acid as a component
of its K-antigen polysaccharide49. The amount of glucuronic acid within a sample can be quantified
and used as an indirect method of determining capsule production53. Srinivasan et al. 2012 showed
that a K. pneumoniae ompK36 knockouts from strain NTUH K2044 of K1 serotype had a
significantly decreased production of glucuronic acid compared to the wildtype25. Conversely, Tsai
et al. 2011 noted a more mucoid appearance of colonies indicative of increased capsule production
for ompK36 mutants for K. pneumoniae NVT1001 of K2 serotype10. This alteration to capsule
production due to porin loss could potentially impact the bacterial resistance to phagocytosis by
macrophages in vitro2 and requires further investigation as it may be serotype dependent.
Klebsiella pneumoniae pathology
Since porins are surface antigens that interact with immune cells, loss of either porin due
to environmental selective pressures can ultimately result in altered interactions with the immune
system. Before this can be considered, it is important to understand normal pathology for K.
pneumoniae.
Klebsiella pneumoniae is an enteric bacterium that is also an opportunistic pathogen.
Initial colonization of the gut is an important step in K. pneumoniae pathogenesis that is required
for the establishment of other infections39. This includes pneumonias, liver abscesses, urinary
tract infections, and bacteremia. Klebsiella pneumoniae is part of a group of bacteria referred to
as the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacter species)54.
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These bacteria are known for being highly adaptable to environmental pressures. This is
especially true for rapid adaptation to antibiotics and the immune system during respiratory
infection54,55.
Klebsiella pneumoniae possesses numerous virulence factors that have developed during
co-evolution alongside the host innate and adaptive immune systems18,54,56. This includes
production of a protective layer of capsular polysaccharide, referred to as the capsule. The
capsule is essentially a slimy layer that surrounds the bacteria, making the bacteria difficult for
professional phagocytes to ingest50,57. It can also act as a protective layer against complementmediated killing by masking other bacterial surface antigens like the LPS or outer membrane
proteins that trigger the complement cascade in vitro.58 Certain serotypes of capsule can be
especially dangerous as they incorporate sugars, like sialic acid, that are typically expressed by
mammalian cells. The expression of sialic acid in the capsule can then be recognized by the
immune system as “self” and will not be targeted as a pathogenic invader59.
Colonization of epithelial cells or indwelling abiotic surfaces, such as catheters, is an
important step in K. pneumoniae pathology54,55. Studies have shown that for K. pneumoniae
infections to persist, colonization of the gut is also necessary39. Adherence to surface, whether
epithelial lining of the lung, gut, or a catheter, is dependent on bacterial proteins that anchor the
bacteria to the surface. This attachment must be strong enough to withstand mechanical forces
such as coughing, blood flow, and peristalsis23,39,55. Fimbriae are the proteins that are primarily
responsible for this attachment in K. pneumoniae54,60. The outer membrane protein OmpA has
also been indicated as an adhesin involved in attachment and invasion of epithelium2,44,45.
Like most Gram-negative bacteria, K. pneumoniae is also adept at evading the
inflammatory response. Lipopolysaccharide is a highly immunogenic molecule that activates

14

toll-like receptor 4 (TLR-4) and elicits a strong inflammatory response55. However, K.
pneumoniae can avoid this activation by genetic switching of antigenic determinants within the
LPS. Attenuated inflammatory responses can allow for the establishment and maintenance of
more severe infections LPS 1,2,58,61.
Evasion of the innate immune system and attenuation of the inflammatory response are
two of the most efficient tactics for the successful infection of the host used by K.
pneumoniae23,54,56. Recent studies have focused on understanding the mechanisms involved.
Frank et al. 2013 showed K. pneumoniae targets a PI3-kinase signaling pathway that blocks the
transcription factor NF-ᴋB from entering the nucleus to mediate the inflammatory response of
A549 lung epithelial cells in vitro. The suppression of the inflammatory response was dependent
of capsule production, as capsule mutants did invoke an inflammatory response55.
Another study from the same lab showed that K. pneumoniae survives phagocytosis by
macrophages by activation of another PI3-kinase signaling pathway that causes the subversion of
phago-lysosomal maturation and ultimately results in induction of apoptosis in vitro. The
bacteria can then escape the macrophage during apoptosis and begin to proliferate
extracellularly. This was not dependent on capsule production, however, as capsule mutants were
still able to survive within macrophages in vitro62.
Clinical studies have also revealed an emergence of hypervirulent mucoviscous K.
pneumoniae56 as well as an increase in the prevalence of carbapenem resistant K. pneumoniae
(KPC)18,54. The current hypothesis is that the rapid adaptation to antibiotics and to the innate
immune system together have resulted in a more dangerous pathogen18,56,63. This is especially
true in areas with unrestricted use of antibiotics as community acquired infections in healthy
children are becoming more prevalent64. This pathogen is constantly adapting and evolving to
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environmental pressures, making a full understanding of its interactions with the immune system
both difficult and necessary.
Vaccine potential for OmpK35 and OmpK36
Multiple studies have shown the potential for OmpK35 and OmpK36 as vaccine
candidates, because both porins elicit an immune response that confers protection against lethal
challenge of live bacteria in vivo10,65. Research looking at the vaccine potential for both OmpK35
and OmpK36 homologues span across multiple Gram-negative species including E. coli, K.
pneumoniae, Salmonella, Shigella, Aeromonas hydrophila, Psuedomonas aeruginosa and Vibrio
cholera15,65–72.
To assess the immunogenicity of OmpC and OmpF in vivo, Liu et al. 2012 injected purified
recombinant OmpF and OmpC into mice and measured the IgG1 and IgG2 antibody titers. After
both the first and second injections of recombinant protein, IgG1 and IgG2 titers were higher in
both OmpF and OmpC treated mice than in the adjuvant injected mice. OmpF had higher IgG1
and IgG2 titers than OmpC, and both OmpF and OmpC showed higher titers for IgG1 over IgG2.
This indicates that both OmpF and OmpC can produce a mixed cell-mediated and humoral immune
response. Mice immunized with the recombinant proteins were protected against lethal challenge
with live bacteria as well, making the case for OmpC and OmpF as vaccine candidates.15
Interestingly, in contrast to other Gram-negative enteric species, OmpK36 DNA vaccines
from K. pneumoniae promote a pro-inflammatory Th1 immune response over a Th2 response in
vivo, indicating a cell-mediated response. However, Th2 indicators were also increased during
immunization with OmpK36 so a humoral response is also possible. Immune sera containing antiOmpK36 antibodies increased opsonophagocytic killing assays in vitro (95.2% intradermal
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administration, 82.4% intramuscular administration) and mice immunized against OmpK36 also
conferred 100% protection via intradermal vaccination in vivo65.
Collectively, these studies show immune cell recognition of recombinant OmpC, OmpF
and OmpK36 and the ability of these proteins to induce an immune response. The vaccine potential
of the porins is increased by the protective effect vaccination with recombinant porins had on lethal
challenge in vivo. However, ESBL positive clinical isolates that are both resistant to antibiotics
and pose a threat in a hospital setting are likely to exhibit porin loss to some degree. Therefore, it
is important to investigate how loss of one or both porins will alter the bacterial interaction with
the host.
Porin loss impact host-pathogen interactions
Porin loss in clinical isolates is a common phenomenon and significantly changes the way
the bacteria interact with cells of the immune system as seen in many Gram-negative opportunistic
pathogens. Isogenic porin knockouts created in the lab show a correlation of porin loss with a
decrease in overall virulence both in vitro and in vivo2,10,20. Porin loss alters the way the pathogen
interacts with phagocytic cells, activates the classic complement pathway, elicits an immune
response, and reduces the ability of the bacteria to cause fatal infection in a mouse model2,10,47,73.
Complement mediated killing of K. pneumoniae begins with the binding of OmpK36 to
the C1q complement protein. This activates the classic complement pathway and results in
destruction of the bacteria. Alberti et al. 1993 showed that outer membrane porins (OmpK36 in
particular) but no other outer membrane components (LPS or CPS) activate this particular pathway
in human sera in vitro that leads bacterial killing13. In a similar study involving E. coli it was shown
that loss of the OmpC porin lead to increased survival in human serum in vitro by evading
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activation of the antibody dependent classic complement pathway. All assays using OmpC
deficient E. coli were inefficient at bacterial killing. This demonstrates the possible ability of
clinical isolates without OmpC expression to evade complement mediated killing in the host74.
In K. pneumoniae multiple independent studies have shown that loss of OmpK36 results
in a decreased resistance to phagocytosis. Tsai et al. 2011 used neutrophil phagocytosis assays in
vitro to determine the percent phagocytosis of OmpK35 and OmpK36 isogenic mutants and
observed lethal effects of the bacteria in a peritonitis mouse model in vivo. The results concluded
that loss of OmpK36 or both porins significantly reduced phagocytic resistance to neutrophils.
Interestingly, loss of only OmpK36 (compared to the wildtype) resulted in a significantly increased
survival time and slightly decreased death rate (10% survival compared to 0% survival by mice
infected with wildtype); while loss of only OmpK35 had no effect on lethality. However, loss of
both porins resulted in a significantly increased survival time and decreased death rate of the mice
(50% compared to 0 %)10. This indicates an overall importance of OmpK36 as a virulence factor
with a lesser emphasis on OmpK35.
Importance of OmpK36 in K. pneumoniae pathogenesis was also discussed by March et
al. 2013. Both Dictyostelium discoideum (an amoeba) and murine macrophages demonstrated
increased phagocytosis of bacteria lacking OmpK36 as opposed to those expressing it in vitro.
This study also looked at the role of OmpK36 in infection and dissemination in vivo in a mouse
model. Mice were infected intranasally and 24 or 72 hours post infection the mice were sacrificed.
Bacterial load in peripheral organs was used to determine dissemination. Although the mutants
could colonize the trachea and cause infection in the lungs, bacterial load in the lungs was
significantly decreased after 72 hours post infection. The mutants were also able to migrate to the
spleen and liver but were significantly lower in bacterial load after 72 hours post infection2. This
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study made it clear that although porin loss does decrease virulence, porin loss isolates would still
be able to establish an infection in the host and pose a problem for immune compromised
individuals.
Klebsiella pneumoniae OmpK36 has also been indicated as being potentially important for
survival in the harsh conditions of the host environment. When bacterial growth was examined in
vitro in the presence of increasing concentrations of bile salts, hydrogen peroxide (reactive oxygen
species), and two different reactive nitrogen species it was evident that loss of OmpK36 resulted
in a decrease in survival. As these conditions mimic those found in a host (gut or phagolysosome)
this study pointed out possible reasons for decreased virulence and pathogenicity of OmpK36
mutants observed when incubated with Caenorhabdits elegans infection model in vivo25.
All Gram-negative species of bacteria secrete outer membrane vesicles (OMVs), the
contents of which mimic that of the outer membrane. Klebsiella pneumoniae OMVs purified from
strains exhibiting differential expression of OmpK35 and OmpK36 elicited unique immune
responses in a macrophage tissue culture model in vitro. Loss of OmpK36 or both porins showed
a significant decrease in production of Mip2 which is important for the chemotaxis of neutrophils.
Dual porin loss also resulted in significant depression of the TNF-α inflammatory response. These
data indicate a significant impact on the immune response, particularly for strains exhibiting loss
of both porins, that may result in suppression of the inflammatory response47.
Thesis Aim
Porin loss in Klebsiella pneumoniae is a clinically important phenomenon that has been
shown to alter both antibiotic resistance as well as pathogenicity of the organism. There is a lack
of information surrounding the impact porin loss has on transcriptional expression of other outer
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membrane proteins, capsule production, and LPS content. These factors have been previously
implicated as important virulence factors, therefore alterations due to porin loss could contribute
to the diminished pathogenicity previously observed. Therefore, the hypothesis is that loss of
OmpK35 and/or OmpK36 will alter the cell surface and result in altered resistance to phagocytosis
by macrophages. The present study aimed to determine the downstream effects porin loss had on
other aspects of the outer membrane. Utilizing clonally related clinical isolates exhibiting
differential porin expression (Figure 4A), the impact porin loss has on growth, capsule, LPS, and
transcriptional expression of other outer membrane proteins was determined. These aspects were
chosen as previous investigation has implicated that these components could potentially confer
resistance or susceptibility to phagocytosis.

20

A. Protein gel

Porin Expression
OmpK35
OmpK36

10R

10R+16K

-

+
-

10S 10S+16K
+

+
+

B. ompK35
**

**

**

10

5

0
10R

+
+

C. ompK36
Relative Expression (AU)

Relative Transcription (AU)

15

43816

10R+16K

10S

10S+16K

0.18
0.16
0.14
0.12
0.1
0.08
0.06
0.04
0.02
0

**

**

10R

10R+16K

10S

10S+16K

Figure 4. A) Outer membrane from each strain was purified and proteins were visualized on a 12% SDS-PAGE gel
using SYPRO Ruby stain. Outer membrane profiles of clinical isolates exhibiting differential porin expression of
OmpK35 and OmpK36 and a lab strain (ATCC 43816) used in this study. Transcriptional expression of outer
membrane proteins by qPCR and analyzed using the ΔΔCt method. Genes are normalized to gapA and clinical
isolates are normalized to the lab strain 43816. B) ompK35 and C) ompK36 transcriptional expression corresponds to
protein profiles of SDS-PAGE gels. *p<0.01 **p<0.0001 compared to 10S+16K n≥7 from at least 2 independent
cultures.
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It was expected that porin loss would have an impact on the production of capsular
polysaccharide. The assay showed that loss of a single porin decreased the overall amount of
capsule produced, but loss of both porins increased capsule production. The amount of LPS was
also expected to be altered by loss of one or both porins, which was also supported by the data.
Previous study has indicated that loss of OmpK35 or OmpK36 has a significant impact the
expression of other outer membrane porins in a compensatory fashion but there is insufficient
evidence for the impact porin loss has on structural proteins. The present study showed that loss
of one or both porins is compensated for by increased expression of oligo galacturonate specific
ompK26 or the maltoporin lamB. The expression of the structural proteins, ompA and lpp, were
also modified in response to porin loss. Surprisingly, there was a significant impact on resistance
to phagocytosis by loss of a single porin, but not both. Based on these findings and others we
conclude that although porin loss has a large impact on the cell envelope of K. pneumoniae, these
cumulative changes do not necessarily predict resistance to phagocytosis. However, other aspects
of macrophage-pathogen interactions may be more affected by porin loss and requires further
study.
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Chapter 2
Porin loss affects the cell envelope of Klebsiella pneumoniae and overall resistance to
phagocytosis by macrophages
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Methods
Bacterial strains, plasmids, and media
Clonally related clinical isolates were cultured from a single patient during a clinical
outbreak and were provided by Dr. Sebastian Alberti (University of the Balearic Islands, Palma de
Mallorca, Spain). Isolates CSUB10R (10R) expressed neither porin and CSUB10S (10S)
expressed only OmpK365. A plasmid carrying the ompK35 gene (pSHA16K) was transformed into
CSUB10R and CSUB10S to create CSUB10R+ pSHA16K (10R+16K) which expressed only
OmpK35 and CSUB10S + pSHA16K (10S+16K) which expressed both porins. These clinical
isolates have been previously characterized as extended spectrum β-lactamase positive (ESBL)
and have high minimum inhibitory concentrations for several β-lactam antibiotics5. All isolates
were grown in Luria-Bertani broth at 37°C with 16µg/mL cephalothin to maintain the antibiotic
selective pressure present when isolated. Isolates 10R+16K and 10S+16K were also grown with
50µg/mL kanamycin for plasmid maintenance.
The lab strain ATCC 4381675 contains no known antibiotic resistance plasmids and has
been characterized as ESBL negative. This strain was used as a basis for comparison of the clinical
isolates against a less antibiotic resistant and virulent strain expressing both porins. It was grown
in Luria-Bertani broth at 37°C.
Growth
Growth curves were performed by inoculating 50mL of fresh Luria-Bertani broth
(supplemented with antibiotics when appropriate) with a 1:1000 dilution of overnight culture. The
OD600 was determined using an Eppendorf Bio photometer every 30 minutes for 6.5 hours.
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Overnight cultures (approximately 15 hours) were serially diluted and plated onto LuriaBertani agar plates and incubated at 37°C overnight. Colony forming units (CFUs) were counted
and CFUs/mL were calculated to determine the effect porin loss has on the concentration of an
overnight culture. Colony morphology was visualized by streak plating onto Luria-Bertani agar
plates. The plates were observed approximately 15 hours after plating.
Outer membrane isolation
The outer membrane was isolated using previously described methods 3. Cultures were
grown overnight; 1 mL of overnight culture was used to inoculate 100mL of fresh Luria-Bertani
with the appropriate antibiotic and grown to an OD600 between 1.5-2.0. Cultures were then
centrifuged at 10,000xg for 10 minutes. The cell pellet was resuspended in Tris-sucrose solution
(20mM Tris, 20% sucrose, pH 8.0). The cell wall was digested using lysozyme (15mg/mL) in
0.1M EDTA solution for 40 minutes and then 0.5M MgCl2 was added to the lysate. The mixture
was centrifuged for 20 minutes at 12,000xg and the supernatant decanted. The pellet was dissolved
in 10mM Tris (pH 8.0) and sonicated on ice. Cellular debris was pelleted and the supernatant
containing the membranes was further centrifuged at 40,000xg for 60 minutes. The pellet was
resuspended in DI water. The membrane fractions were treated with Sarkosyl solution at room
temperature for 20 minutes and centrifuged at 40,000xg for 90 minutes. The pellet containing outer
membrane was resuspended in 1X PBS. Protein concentration was determined using a standard
Bradford assay (Coomaisse Plus, Thermofisher). Proteins were visualized on a 12% SDS-PAGE
gel using the SYPRO Ruby stain from Molecular probes76. Minimum Inhibitory Concentration
Overnight cultures were diluted to a suspension containing approximately 103 CFUs/mL in
LB media in a 96 well microtiter plate. Bacteria were treated with 500, 250, 125, 62.5, 31.25, 16,
8, 4, 2, 1, and .5 µg/mL of cephalothin, gentamicin, or colistin. Wells containing only LB were
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used as controls for normal growth. The absorbance of each well at OD600 was measured using a
Biotek Gen5 plate reader. The minimum inhibitory concentration was determined as the lowest
concentration at which growth was significantly inhibited (by at least 90%) as defined by the
Clinical and Laboratory Standards Institute (CLSI)77.
Capsular polysaccharide characterization
Capsular polysaccharide (CPS) was extracted using the protocol outlined by Domineco et
al53. From an overnight culture, 500µL was mixed with 100µL of 1% Zwittergent 3-14 in 100mM
citric acid, pH 2.0. The mixture was vortexed vigorously, incubated at 50°C for 20 minutes, and
centrifuged for 5 minutes at 14,000 rpm. The supernatant was transferred to a 2mL Eppendorf tube
and mixed with 1.2mL of absolute ethanol and incubated for 90 minutes at 4°C. Precipitate was
collected after centrifugation at 14,000 rpm for 10 minutes and then dissolved in 200µL DI water.
CPS was quantified following previously established protocol by Lin et al78. Samples were
vortexed vigorously with 1.2mL of 12.5mM sodium tetraborate in concentrated sulfuric acid and
heated for 5 minutes at 95°C. The samples were allowed to cool before the addition of 20µL of
0.15% m-hydroxydiphenyl. The absorbance at 540nm was measured with a Biotek Gen5 plate
reader. A standard curve was generated using D-glucuronic acid in order to determine the
concentration of glucuronic acid of the CPS samples. To ensure quantification of CPS from the
same number of bacteria, CFUs/mL were determined and strains were normalized to 108
CFUs/mL. Each assay was performed in triplicate from 6 individual cultures.
To determine the molecular weight distribution of the capsule, a sample of the capsule
containing 10µg of glucuronic acid was run on a 12% SDS-PAGE gel. Polysaccharide was
visualized using the ProQ Emerald 300 staining kit by Molecular probes79.
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Capsule was stained using overnight cultures and a 10% nigrosin solution. An inoculation
loop was used to add bacteria to the slide and mixed with 1µL of nigrosin. The solution was spread
across the slide and allowed to air dry. The slide was visualized at 1000x total magnification with
a compound light microscope.
Lipopolysaccharide Quantification
To quantify LPS of whole cell bacteria, a previously described purpald assay method was
used47,80. This assay detects the 3-deoxy-D-manno-oct-2-ulopyranosonic acid (KDO) molecule of
the LPS. Cultures were grown overnight, washed in 1X PBS, and 50µL of suspension in 1X PBS
was mixed with 50µL of 32mM sodium periodate. After 25 minutes of incubation at room
temperature, 50µL of 136mM purpald in 2N NaOH was added to each well of a 96 well plate. This
was incubated at room temperature for 20 minutes and 50µL of 64mM sodium periodate was
added. After 20 minutes of incubation at room temperature, air bubbles were removed using 10µL
isopropanol. Samples were read at 540nm using a Biotek Gen5 plate reader. A standard curve was
generated using purified K. pneumoniae LPS. To ensure quantification of LPS from the same
number of bacteria, CFUs/mL were determined and strains were normalized to 108 CFUs/mL.
Isolated outer membrane samples were used to visualize the LPS with a 12% SDS-PAGE
gel using approximately 4µg of LPS as determined by the purpald assay. Polysaccharide was
stained using the ProQ Emerald 300 staining kit by Molecular Probes79. High molecular weight
polysaccharide indicates smooth LPS, while low molecular weight polysaccharide indicates rough
LPS.
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Transcriptional expression of outer membrane proteins by qPCR
RNA was extracted from cultures in the exponential phase using the RNeasy kit by Qiagen
with DNase treatment. Complimentary DNA (cDNA) was reverse transcribed from 1µg of total
RNA using random hexamer primer and the ProtoscriptII reverse transcriptase kit (New England
Biolabs). Quantitative polymerase chain reaction (qPCR) was performed using LuminoCt SYBR
green on an Eppendorf Mastercycler Realplex 2. Data was analyzed using the ΔΔCT method81.
Gene expression was normalized to that of gapA and clinical isolates were normalized to the lab
strain 43816. Primers used are listed in Table 1.
Table 1. Primers used for qPCR.
Gene
gapA
OmpK35
OmpK36
ompK26
lamB
ompA
Lpp

Forward primer
TTGACCTGACCGTTCGTCTGGAAA
TTCGACAACGCTATCGCACTGTCT
CCGTCAACCAGACCGAAGAA
GAACAACGCCCGGCAAGATGATGA
GCGGGTAAACGCTTCTATCA
ACGTGCTCAGTCCGTTGTTGACTA
CGGTAATCCTGGGTTCTACTCT

Reverse primer
AGCATCGAACACGGAAGTGCAAAC
AGTACATGACGGCCGCATAGATGT
CAGGCCTGAAATTTGGCGAC
AGCTGCGGGCATAGACATAGTTCA
GGTCAACGTTTTCCAGACCT
AGTAACCGGGTTGGATTCACCCAT
TGCTCAGCTGGTCAACTTTAG

Phagocytosis assay
Murine macrophage cell line RAW 264.782 was maintained in 1640 RPMI media
supplemented with 10% fetal bovine sera and penicillin, streptomycin, and amphotericin B at 37°C
in 5% CO2. Macrophages were seeded into a 24 well tissue culture plate at 7.5x105 cells/mL and
incubated overnight. Overnight bacterial cultures were suspended in a 1X PBS solution to contain
approximately 1x109 CFUs/mL. Macrophages were treated with bacteria at a multiplicity of
infection (MOI) of 50:1, infection was synchronized using centrifugation at 200xg for 5 minutes,
and incubated at 37°C for 15 minutes. Macrophages were washed with 1X PBS to remove nonmacrophage associated bacteria and then lysed with 0.1% Triton X-100 in 1X PBS. Solution was
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serially diluted, plated on LB agar plates, and incubated overnight at 37°C. To determine the
number of macrophage-associated bacteria, colony forming units were counted and CFUs/mL
were calculated. Percent phagocytosis was determined by dividing the number of CFUs/mL
recovered by the CFUs/mL of the original inoculum.
Statistical Analysis
All experiments were performed with n≥3. Statistical significance was determined using a
one-way ANOVA and Tukey’s post hoc test using XLSTAT software. Significance compared to
10S+16K is determined at p values of <0.01 (*) and p<0.0001 (**).

Results
Rate of growth, colony morphology, and cell density of Klebsiella pneumoniae clonally
related clinical isolates
Porins are partially responsible for nutrient acquisition required for the growth and division
of the cell. Therefore, porin loss could potentially impact bacterial cultures at all stages of growth.
To determine this, standard bacterial growth curves were performed. However, growth curves
determined there was no significant difference in growth during the lag, exponential, or stationary
phases between any of the strains. (Figure 5A). However, clinical isolate 10R+16K did
demonstrate a slightly depressed cell density during the stationary phase at 6 and 6.5 hours when
compared to 10S+16K (p=.015 and p=.027 respectively). Isolate 10R+16K also exhibited
alterations to colony morphology on LB agar streak plating. Colonies were visibly smaller and less
mucoid in appearance than those of the other isolates and the lab strain (Figure 5C). To determine
whether this depressed growth and colony morphology affected cell concentration of an overnight
culture, CFUs/mL were found. The 10R+16K strain had similar CFUs/mL as all other strains
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indicating that loss of OmpK36 in this strain did not affect bacterial cell concentration of overnight
cultures (Figure 5B).
Minimum inhibitory concentration is increased with loss of one or both porins in an ESBL
background
The clinical isolates showed minimum inhibitory concentrations above the CLSI defined
clinical resistance level for both cephalothin (32µg/mL) and gentamicin (8µg/mL) (Table 2). The
lab strain, with no known antibiotic resistance mechanisms associated with it, was below that
threshold for all tested antibiotics. This was predicted as the clinical isolates have previously been
characterized as ESBL positive and are expected to be clinically resistant5. However, porin loss
within the clinical isolates did show an increase in minimum inhibitory concentrations for
cephalothin and gentamicin. 10S+16K had an MIC of 125µg/mL for cephalothin and 62.5µg/mL
for gentamicin. Loss of OmpK36 resulted in a 2-fold increase in MIC for both cephalothin and
gentamicin compared to 10S+16K. Loss of OmpK35 increased the MIC for cephalothin by at least
4-fold compared to 10S+16K but did not alter resistance to gentamicin. Loss of both porins caused
a greater than 4-fold increase in the MIC of cephalothin and a 2-fold increase for gentamicin
compared to 10S+16K. All clinical isolates and the lab strain were susceptible to colistin.
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Figure 5. Loss of OmpK36 depresses the stationary phase and alters colony morphology, but does not significantly
impact cell density of an overnight culture. A) Standard growth curves of clonally related clinical isolates and a lab
strain of Klebsiella pneumoniae. OD600 was measured every 30 minutes for 6.5 hours. No significant difference among
the strains was found using an ANOVA. n=3. Error bars indicate one standard deviation from the mean. B) Overnight
cultures were serially diluted, plated onto LB agar plates, and grown overnight at 37°C. Colony forming units were
counted and CFUs/mL calculated. Porin loss does not affect CFUs/mL of an overnight culture. n≥5. Error bars indicate
one standard deviation from the mean. C) Overnight cultures were streak plated on LB agar plates and grown overnight
at 37°C. 10R+16K has visibly smaller and less mucoid colonies than 10S+16K.
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Table 2. Minimum inhibitory concentrations were determined using a standard microdilution method. Breakpoint
MIC is defined as the concentration at which growth is first inhibitted by at least 90%. Resistance is determined as
suggested by the Clinical and Laboratory Standards Institute29. Loss of both porins resulted in a 4 fold increase in MIC
for cephalothin and a 2 fold increase for gentamicin.

Strain
10R
10R+16K
10S
10S+16K
43816
CLSI
Resistance

Breakpoint MIC
Porin Expression
Cephalothin Gentamicin Colistin OmpK35 OmpK36
>500
125
2
>500
62.5
1
+
250
125
2
+
125
62.5
<.5
+
+
2
4
1
+
+
>32

>8

>2

Capsule production is affected by loss of one or both porins
Capsular polysaccharide was extracted and the production of capsule was indirectly
quantified by glucuronic acid concentration (Figure 6A). Both 10R +16K and 10S produced
significantly less capsule than 10S+16K. Interestingly, loss of both porins in clinical isolate 10R
had a contrasting effect on capsule production and had a significant increase. The lab strain 43816
produced similar amounts of capsule as the clinical isolate 10S+16K.
Capsule was also visualized on a 12% SDS-PAGE gel and stained with ProQ Emerald 300
for polysaccharide (Figure 6B). There did not appear to be any major differences between isolates,
other than a slight decrease in staining for lower molecular weight polysaccharides for 10R+16K.
Further investigation into the molecular makeup of the capsule would need to be done to determine
whether this absence of staining is due to a decrease in glucuronic acid or another monosaccharide.
Negative staining using 10% nigrosin was used to physically observe the size of the capsule
surrounding the bacteria. Visualization at 100X under oil immersion revealed a less distinct
capsule for 10R+16K compared to the other isolates (Figure 6C).
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Figure 6. Quantification and visualization of capsular polysaccharide. A) Capsule was extracted and glucuronic acid
was quantified (µg/108 CFUs) using a standard curve. Loss of OmpK35 and OmpK36 alone resulted in significantly
decreased capsule production while loss of both porins resulted in significantly increased capsule production. *p<0.01,
**p<0.0001 compared to 10S+16K n≥9. B) Extracted capsule was ran on a 12% SDS-PAGE gel and stained using
ProQ Emerald stain. 10R+16K shows a decrease in staining for lower molecular weight polysaccharides compared to
10S+16K. C) Overnight cultures were stained using 10% nigrosin to visually observe capsule at 1000X total
magnification. Red line equals 0.58µm.
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Lipopolysaccharide content is increased with porin loss
Bacteria were assayed for LPS using the Purpald assay to determine whether porin loss
impacted the LPS content (Figure 7A). There was a significant difference in the amount of LPS
between clinical isolate 10S+16K and the lab strain 43816. Compared to 10S+16K, the isolates
with loss of one or both porins exhibited increased LPS content.
To address whether LPS composition was affected by porin loss, purified outer membrane
samples were analyzed by SDS-PAGE and stained for polysaccharides using ProQ Emerald stain
(Figure 7B). The clinical isolates all exhibited lower molecular weight polysaccharide LPS that is
synonymous with less virulent strains, however, the lab strain had higher molecular weight LPS
that is indicative of a more virulent strain. This indicates potential differences in LPS structure and
composition between the clinical isolates and the lab strain. Clinical isolate 10R+16K did have
visibly decreased staining for LPS than all other strains and may have modifications to the LPS
due to porin loss.
Transcriptional expression of outer membrane proteins in response to porin loss
Quantitative PCR showed that loss of one or both porins can have a significant impact on
the transcriptional expression of other outer membrane proteins. Genes assayed were chosen due
to individual importance in compensation for porin function (ompK26 and lamB) or cell envelope
stability (ompA and lpp). Transcriptional expression of ompK35 and ompK36 were also assayed
and were consistent with porin expression seen in SDS-PAGE gels (Figure 4B and 4C). Clinical
isolates 10S, 10R+16K and 10R all showed a significant increase in expression of ompK26
compared to 10S+16K (Figure 8A), however only 10R+16K showed a significant increase in
expression of lamB (Figure 8B).
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Figure 7. Quantification and visualization of lipopolysaccharide. A) Whole bacteria were assayed for LPS by
quantifying the KDO molecule of the LPS through the purpald assay. LPS was measured in µg LPS/108 CFUs.
*p<0.01, **p<0.0001 compared to 10S+16K. n= 18 from 3 independent cultures. B) LPS composition from isolated
outer membrane samples was observed by staining for polysaccharide using ProQ Emerald stain on a 12% SDS-PAGE
gel. Clinical isolates exhibit rough LPS synonymous with less virulent form of LPS and the lab strain exhibits smooth
LPS more indicative of virulent LPS.

35

Relative Transcription (AU)

A. ompK26

1.4
1.2
1
0.8
0.6
0.4
0.2
0

Relatvie Transcription (AU)

B. lamB

**

*

**

10R

10R+16K

10S

6

10S+16K

**

5
4
3
2
1
0
10R

10R+16K

10S

10S+16K

Porin Expression
OmpK35

-

+

-

+

OmpK36

-

-

+

+

Figure 8. Transcriptional expression of alternative outer membrane proteins by qPCR and analyzed using the ΔΔCt.
Genes are normalized to gapA and clinical isolates are normalized to the lab strain 43816. A) ompK26 expression is
increased for loss of one or both porins. B) LamB transcriptional expression is increased for loss of OmpK36 only.
*p<0.01 **p<0.0001compared to 10S+16K n≥7 from at least 2 independent cultures.
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This indicates that loss of OmpK35 or both porins is compensated for by OmpK26, but loss of
OmpK36 alone is primarily compensated for by the maltoporin LamB and supplemented with
OmpK26.
Both OmpA and Lpp have been previously characterized as being crucial for the
maintenance of outer membrane and cell envelope integrity, but have not been thoroughly
investigated for their roles in porin loss. The transcriptional expression of ompA was decreased for
both 10S and 10R+16K when compared to 10S+16K but no significant difference was found for
10R (Figure 9A). Interestingly, expression of lpp was significantly increased for 10R+16K, but
significantly decreased for 10S and 10R compared to 10S+16K (Figure 9B).
Phagocytosis is affected by loss of a single porin
Phagocytosis assays were performed to determine how porin loss alters resistance to
phagocytosis by murine macrophages. First, the number of macrophage associated bacteria were
determined by counting CFUs recovered from each well. The percent phagocytosis was calculated
by dividing the number of recovered bacteria by the number of bacteria in the original inoculum
(Figure 10). The clinical isolate 10S+16K and the lab strain 43816 showed similar resistance to
phagocytosis as there was no significant difference in percent phagocytosis between them.
However, 10R+16K and 10S had increased phagocytosis by macrophages compared to 10S+16K.
None of the clinical isolates were significantly more resistant to phagocytosis than 10S+16K.
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Figure 9. Transcriptional expression of structural outer membrane proteins using qPCR and analyzed using the ΔΔCt.
Genes within each isolate were normalized to gapA and isolates were normalized to 43816. A) Loss of a single porin
resulted in a decrease in expression of ompA. B) Loss of OmpK36 resulted in a significant increase in lpp expression,
but loss of OmpK35 or both porins resulted in a significant decrease. n≥7 from at least 2 independent cultures. *p<0.01
**p<0.0001 compared to 10S+16K.
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Figure 10. Phagocytosis assays were performed using an MOI of 50:1. Colony forming units from macrophage
associated bacteria were counted and CFUs/mL determined. Percent phagocytosis was found by dividing the number
of recovered CFUs/mL by the number of CFUs/mL of the original inoculum. The percentage of phagocytosis was
increased by loss of OmpK35 (p<0.0001) and OmpK36 (p=0.012) but not both porins (p=0.776) compared to
10S+16K, n=9.
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Discussion
This study hypothesized that the loss of OmpK35 and/or OmpK36 would alter the cell
surface and result in altered resistance to phagocytosis by macrophages. These isolates adapted to
environmental pressures of antibiotics that resulted in loss of one or both porins. Previous studies
have focused on the role porin loss plays in antimicrobial and phagocytic resistance, but there is
insufficient research looking at the effect porin loss has on other aspects of the cell. Here, it is
demonstrated that porin loss has a significant impact on capsule and LPS content, and affects the
transcriptional expression of other outer membrane porins. In addition, these cumulative changes
alter phagocytic resistance by murine macrophages and may, therefore, impact other aspects of the
immune response.
Growth, cell density, and colony morphology were determined to first assess the clinical
isolates. While there was a slightly lower OD600 in the stationary phase and visibly smaller colonies
for loss of OmpK36 (10R+16K), CFUs/mL of an overnight culture (within the stationary phase)
were no different than the strain with both porins. This indicates something else is contributing to
the differences in colony size and absorbance/cell density for this strain. Capsule production within
this strain is also severely decreased compared to 10S+16K (expresses both porins) so it is possible
that these differences are due to a decrease in the capsular polysaccharide surrounding the bacteria.
Glucuronic acid quantification and negative staining showed that the amount of capsule
produced by each strain was significantly decreased by loss of either porin (10R+16K and 10S),
but significantly increased by loss of both (10R). Previous studies of the relationship between porin
loss and capsule production are contradictory. One study showed that capsule production
decreased in an ompK36 knockout25 and another described an ompK36 knockout as being more
mucoid in appearance, indicating an increase in capsule production10. Interestingly, these
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contrasting studies used K. pneumoniae strains with different capsular serotypes (K1 and K2
respectively) than the strains tested here (unknown). Capsule serotype is based on the specific
structure of the capsular polysaccharide for each strain. This structure is antigenic and can be
recognized by specific antibodies50,51,57. It is therefore possible that the impact porin loss has on
the production of capsule could be dependent on serotype.
The serotypes of the strains used in this study were unable to be determined by PCR using
previously published primers for K1, K2, and K5 serotypes (data not shown)51. Further analysis of
the capsule using antigenic serotyping51 would need to be performed to determine the specific
serotype of these isolates. However, it does appear that the effect of porin loss in these clinical
isolates is similar to those of the K1 serotype seen by Srinivasan et al.25. The direct relationship
between capsule and porins has yet to be investigated.

It is unknown whether porins are

responsible for the uptake of the specific monomeric sugars responsible for the creation of the
polysaccharide of the K-antigen. Therefore, it is possible that porin loss could directly impact the
ability of the capsule to be synthesized. This could be tested by treating strains of different
serotypes that exhibit porin loss with radiolabeled sugars. The capsule could be extracted and the
amount of radiolabeled sugars within the capsule determined. If porin loss affects the import of
sugars used in capsule synthesis, then these strains will contain less radiolabeled capsule.
However, data collected in this investigation does not seem to support this as loss of a single porin
decreased capsule and loss of both porins increased the amount of capsule. For this hypothesis to
have been supported, loss of both porins would need to have further decreased capsule production.
Capsular polysaccharide has been identified as a primary indicator for low levels of
phagocytosis. The presence and serotype of the capsule decreases the ability of the phagocytic cell
to recognize, attach, and internalize bacteria. Non-capsule producing K. pneumoniae are
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phagocytosed at higher rates than strains that produce a capsule83,84. The capsular serotype can
also have a dramatic effect on strain virulence as well. K1 and K2 serotypes are notably more
virulent and resistant to phagocytosis than other serotypes50,51,78,84. The clinical isolates used in
this study were unable to be serotyped based on PCR methods and are likely not of the K1, K2, or
K5 serotype. The lab strain 43816 was previously characterized as K2 serotype57. The
phagocytosis assays performed here showed no difference between the lab strain and the clinical
isolate expressing both porins (10S+16K). The capsular polysaccharide assays from this study also
showed no significant difference between the clinical isolate expressing both porins and 43816.
This indicates the capsular serotype of the clinical isolates confers equal protection to phagocytosis
as the K2 serotype.
It was hypothesized that porin loss related capsule production would correlate with
resistance to phagocytosis. This was partially supported as loss of a single porin decreased the
amount of capsule produced by the clinical isolates and increased the percent phagocytosis. In
contrast, the strain 10R that expressed neither porin produced significantly more capsule, but was
not more resistant to phagocytosis than the isolate that expressed both porins (10S+16K). If capsule
was the primary factor for the resistance to phagocytosis, then the increase in capsule for 10R
would have been expected to decrease the percent phagocytosis. However, this was not the case,
indicating that other factors were impacting phagocytosis. This is most likely porin expression as
10R expresses neither porin. In previous studies using K. pneumoniae clinical isolate NVT2001,
loss of both porins led to an increase in phagocytosis by human neutrophils in vitro10. Therefore,
it is possible that in this study the increase in capsule produced by 10R provided some protection
against phagocytosis even with the dual porin loss background. However, the capsule was not
sufficient to further decrease percent phagocytosis.
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Capsule is not the only polysaccharide-based molecule altered by porin loss. The data
presented here demonstrate that loss of one or both porins also significantly increases the LPS
content in cells. Bacteria have a preferred surface area to volume ratio that is maintained for
optimum acquisition and distribution of nutrients throughout the cell85. OmpK35 and OmpK36 are
two of the most abundant proteins of the outer membrane. Therefore, loss of one or both porins
would likely result in a decrease in the surface area of the bacteria. The increase in LPS content in
the outer membrane could be a compensatory mechanism for maintaining a preferred surface area
to volume ratio in response to porin loss.
The purpald assay quantifies the content of the LPS by measuring the KDO molecule, but
does not provide any information regarding the composition of the core antigen or the O antigen
of the LPS. Therefore, the LPS was also analyzed using SDS-PAGE to test for polysaccharide.
There was a visible difference in the molecular weight of the LPS between the clinical isolates and
the lab strain 43816 that is likely due to genetic differences between the lab strain and the clinical
isolates. The clinical isolates exhibited a lower molecular weight polysaccharide that is indicative
of rough LPS, while the lab strain exhibited higher molecular weight indicative of smooth LPS.
Rough LPS has modified O-antigen or has completely lost the O-antigen. Loss of the O-antigen
has been shown to be irreversible in some strains and disables antigenic switching. This decreases
the ability of the bacteria to change its surface structure as a way to evade the immune system86.
Rough LPS has also been described to be more sensitive to complement-mediated killing. This is
because the C3-b complement protein will bind closer to the membrane, which allows for the
formation of the membrane attack complex and the cell is lysed87. Smooth LPS positions the C3b complement protein farther away from the outer membrane and the membrane attack complex
is not formed58.
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Staining for polysaccharide from an outer membrane sample of showed a visible decrease
for the loss of OmpK36 in strain 10R+16K compared to 10S+16K (expresses both porins). The
gel was loaded with equal amounts of LPS as per the purpald assay, therefore a decrease in staining
for polysaccharide indicates alterations to the core antigen or O antigen segments.
Lipopolysaccharide has been well documented as a virulence factor for K. pneumoniae2,3,58, and
the presence of LPS has been shown to aid in evasion of phagocytosis as well. LPS core
polysaccharide core mutants were shown to be more susceptible to phagocytosis than wildtype,
however, O-antigen mutants were not2. In this study, loss of one or both porins (10R+16K, 10S,
and 10R respectively) resulted in a significant increase in the amount of LPS of each strain, and
loss of OmpK36 (10R+16K) resulted in decreased polysaccharide staining. These trends do not
correlate with those seen for resistance to phagocytosis here, so it is unlikely that alterations to the
LPS due to porin loss altered the resistance to phagocytosis. However, alterations to the O-antigen
or core antigens could potentially impact other interactions with the immune system. Specifically,
activation of the classic complement cascade and toll-like receptor 4 (TLR-4) which would
increase secretion of pro-inflammatory cytokines by the macrophages. Activation of TLR-4 would
likely increase for 10R+16K (loss of OmpK36) if alterations to the O-antigen or core antigens
made the pathogen associated molecular pattern for the lipid A portion of the LPS more
accessible88. Further inquiry into the makeup of the O-antigen of these strains using mass
spectrometry would be helpful to determine where the molecular differences lie between the LPS
of the porin loss isolates. This would also give more evidence as to whether alterations to the LPS
due to porin loss contributed to the decrease in resistance to phagocytosis observed by loss of
OmpK36 (10R+16K).
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The transcriptional expression of other outer membrane proteins was also significantly
different between isolates exhibiting porin loss (10R+16K, 10S, and 10R) and the isolate
expressing both porins (10S+16K). This study demonstrated that loss of one or both porins was
compensated for by the upregulation of other specific porins. Transcriptional expression of
ompK26, which is specific for oligo galacturonate (sialic acid) and is impermeable to large βlactam antibiotics, was significantly increased for isolates with loss of OmpK35 (10S), OmpK36
(10R+16K), or both porins (10R). However, loss of OmpK36 (10R+16K) did not result in
upregulation of ompK26 to the same degree as loss of OmpK35 (10S) or both porins (10R) did.
Previously, OmpK26 was shown to be essential for compensation of OmpK36. The Alberti lab
attempted to create an ompK26 knockout in the strain 10R (expresses neither porin) used in this
study, but were unsuccessful without the reversion of OmpK36. This demonstrates that OmpK26
may indispensable when both OmpK35 and OmpK36 are lost40. Therefore, the significant
upregulation of ompK26 seen here was to be expected.
Alberti et al. 2011 also showed that expression of OmpK26 without expression of OmpK36
reduced the virulence of K. pneumoniae. Experiments testing the lethality in a mouse
intraperitoneal infection model revealed the strain that expressed OmpK36 but not OmpK26 was
significantly more fatal. This indicates that OmpK36 is significantly more important for survival
of the bacteria in a mouse model than OmpK26 is. In the data presented here, the isolates exhibiting
loss of either one or both porins also had increased transcriptional expression of ompK26, however,
the expression of OmpK26 was not indicative of evasion of phagocytosis. It would be expected
that strains with upregulation of ompK26 would also have the highest percent phagocytosis.
However, the strains with the highest expression of ompK26, 10R (expresses neither porin) and
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10S (loss of OmpK35), were not the most susceptible to phagocytosis. Therefore, it is unlikely that
ompK26 expression is a good indicator for the resistance to phagocytosis.
LamB is a porin that primarily imports the sugar maltose, although other sugars can also
diffuse through this channel. The strain expressing only OmpK35 (10R+16K) had a significant
increase in lamB expression. Previous experiments have shown a lamB knockout in an
ompK35/ompK36 negative background triggers the expression of ompK26 and increases the
resistance to meropenem (a carbapenem antibiotic)41. It was therefore concluded that LamB may
compensate for the loss of OmpK36. The current study supports this hypothesis (Table 3). The
clinical isolate 10R+16K (loss of OmpK36), expressed ompK26 to a lesser degree than 10R (loss
of both porins) and 10S (loss of OmpK35) and also expressed lamB more than 10R and 10S. This
study provides evidence that OmpK35 and OmpK36 each have individual compensatory porins,
OmpK26 and LamB respectively.
Table 3. Transcriptional expression of porins in clinical isolates.

Strain
ompK35 ompK36 ompK26 lamB
10R
++
10R+16K
+
+
++
10S
+
++
10S+16K
+
+
-

LamB has not been previously characterized as a virulence factor. Interestingly, the strain
expressing the highest relative transcription of lamB, 10R+16K (loss of OmpK36), was also the
strain that had the greatest susceptibility to phagocytosis. Further inquiry into the role LamB plays
in pathogenicity should be done. The specific focus should be to determine whether loss of
OmpK36 or increased LamB on the cell surface increases susceptibility to phagocytosis.
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The structural outer membrane protein, OmpA, is a highly-characterized protein that has
been shown to be multifunctional. This protein has some porin functionality89, is important for the
stability of the cell envelope27, acts as an adhesin to attach the cell to surfaces43, and acquires iron
within the host46. Turner et al. 2016 noted that OmpA content was enriched for outer membrane
vesicles from isolates with loss of OmpK35 (10S), but not for loss of OmpK36 (10R+16K) or both
(10S+16K). This study was performed using the same clinical isolates from the present study47.
Outer membrane vesicles are derived from the outer membrane and can be representative of the
outer membrane4. The data from this study contrasts this finding, as loss of either porin (10R+16K
or 10S) showed a significant decrease in ompA transcription, which is not necessarily indicative
of protein content. However, previous literature has confirmed selective sorting mechanisms for
proteins into outer membrane vesicles and a distinct difference between protein content of the
outer membrane and outer membrane vesicles3,4. Therefore, it is possible that although
transcription of ompA decreases due to loss of a single porin, OmpA is still enriched in outer
membrane vesicles due to this selective sorting mechanism.
OmpA is perhaps the most studied outer membrane protein of Gram-negative species. It
has been well documented for its role in virulence. March et al. showed that K. pneumoniae ompA
knockouts were susceptible to phagocytosis to the same degree as ompK36 knockouts2. Previous
work from the same lab also showed that OmpA deficient bacteria were more likely to induce an
inflammatory response necessary to clear an infection than the strain that expressed OmpA both
in vitro by A549 lung epithelial cells and in vivo in a mouse model45. Together these results
indicate that OmpA contributes to the evasion of the immune response. The current data agree
with this finding because the clinical isolates 10R+16K (loss of OmpK36) and 10S (loss of
OmpK35), which expressed significantly less ompA than 10S+16K (expresses both porins), were
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also the most susceptible to phagocytosis. The isolate 10R (loss of both porins), which expressed
similar amounts of ompA in comparison to 10S+16K (expresses both porins), also showed similar
percent phagocytosis. Therefore, the expression of OmpA observed in this study may be a driving
factor in whether the bacteria would be more resistant or susceptible to phagocytosis by murine
macrophages.
The transcriptional expression of lpp showed that loss of OmpK35 (10S) or both porins
(10R) resulted in decreased expression of lpp, but loss of only OmpK36 (10R+16K) resulted in a
significant increase in expression. This indicates that lpp expression may be sensitive to OmpK35.
While the role of lpp has been well documented for cell envelope stability27, information on Lpp
expression under harsh conditions is lacking. This includes the role Lpp plays in response to porin
loss, exposure to antibiotics, or other toxic compounds. A more in-depth analysis regarding the
impact of porin loss on the expression of proteins such as OmpA and Lpp should be done to
determine the overall effect of porin loss on the stability of the cell envelope.
Previous literature indicates that Lpp expression confers protection from phagocytosis by
neutrophils in vitro and may be important for maintaining cell envelope integrity within the host48.
However, in the present experiments the clinical isolate with the highest lpp expression was also
the least resistant to phagocytosis. This isolate, 10R+16K, was also deficient in OmpK36 and
capsule, which are both indicators of resistance. It is likely then, that OmpK36 and capsule are
better indicators of resistance or susceptibility to phagocytosis than Lpp.
Lastly, this study showed that loss of either porin individually correlated with a significant
increase in percent phagocytosis. This data contrasts slightly with previous literature. Tsai et al.
2011 created isogenic knockouts of ompK35, ompK36, and both porins. Exposure to phagocytic
human neutrophils in vitro showed that loss of OmpK36 or both porins significantly increased
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phagocytosis while loss of only OmpK35 had no effect10. A similar study by March et al. 2013
showed that loss of OmpK36 resulted in an increase in phagocytosis by murine macrophages in
vitro, but did not look at the effect of the loss of OmpK35 or that of both porins2. Here it was
demonstrated that the loss of OmpK35 (10S) or OmpK36 (10R+16K) showed an increase in
phagocytosis by murine macrophages, with the loss of OmpK36 having a greater increase in
phagocytosis than loss of OmpK35 did. The loss of both porins (10R) did not have any effect on
phagocytosis though, which is different from the study done by Tsai et al 2011. The differences
seen between this and previous studies could lie in the other changes observed in the bacteria due
to porin loss or could be due to the differences between the human neutrophils and murine
macrophages used in each study.
The clinical isolates with loss of only one porin (10R+16K and 10S) also exhibited a
decrease in capsule production and expression of the virulence factor ompA. Previous literature
indicates that these strains should also have been more susceptible to phagocytosis based on these
specific changes2,50,90,56. The data on single porin loss from this study supports this. However, the
clinical isolate 10R which expressed neither porin should have been more susceptible to
phagocytosis based on porin expression, but this isolate also exhibited increased capsule
production and equal ompA expression to the isolate with both porins (10S+16K). Both factors
could have compensated for the loss of both porins and provided some protection from
phagocytosis.
The research performed here sheds light on the makeup of the cell envelope in porin loss
clinical isolates, as well as the effect porin loss has on virulence. Here, it is demonstrated that
capsule production, expression of OmpK35 and OmpK36, as well as transcriptional expression of
ompA are the most likely indicators for resistance to phagocytosis by macrophages. However, this
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study also points out some gaps in knowledge that should be addressed in future research. First
and foremost, the role porin loss plays in capsule production across serotypes should be
determined. Assays should be specifically designed to determine how porin loss affects the
amount of capsule produced and the composition of the capsule amongst different serotypes.
Secondly, this study demonstrated that porin loss could potentially affect the LPS content
and composition. The loss of one or both porins significantly increased the content of LPS
compared to the isolate expressing both porins (10S+16K). However, loss of OmpK36 (10R+16K)
showed a decrease in the staining of polysaccharide, indicating alterations to the composition of
the core or O antigen polysaccharides. This especially should be determined as alterations to the
O-antigen or core polysaccharides could potentially alter the inflammatory response of the host88
and alterations to the core polysaccharide could increase susceptibility to phagocytosis2.
Lastly, the effect that porin loss has on the virulence factor OmpA should be more closely
determined. Previous studies done by this lab indicate that loss of one or both porins causes an
enrichment of OmpA in OMVs47, but the current study shows that transcription of ompA decreases
with the loss of one porin (10R+16K and 10S). A better quantitative measurement of OmpA
protein in porin loss species should be constructed to determine what affect porin loss has on the
amount of OmpA protein in the outer membrane. This would aid in determining whether OmpK35,
OmpK36, or OmpA contribute more to resistance to phagocytosis than the transcriptional
expression of ompA does.
The aim of this study was to investigate if the cumulative changes due to porin loss
influence the resistance to phagocytosis. It was demonstrated that loss of one or both porins alters
capsule production, LPS content, and the expression of other outer membrane proteins. These
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changes to the cell surface in response to porin loss had a cumulative impact on phagocytosis by
macrophages.
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